Advancing the use of genome-wide association studies for drug repurposing.

Abstract excerpt

Genome-wide association studies (GWAS) have revealed important biological insights into complex diseases, which are broadly expected to lead to the identification of new drug targets and opportunities for treatment. Drug development, however, remains hampered by the time taken and costs expended to achieve regulatory approval, leading many clinicians and researchers to consider alternative paths to more immediate...

Topics

Join the communities discussing this publication.

• Drug Repositioning
• Gene Regulatory Networks
• Genome-Wide Association Study
• Multifactorial Inheritance
• Pharmaceutical Preparations